Pyoderma gangrenosum: a review

A Neil Crowson1, Martin C Mihm, Cynthia Magro

  • 1Department of Dermatology, University of Oklahoma, Tulsa, OK, USA. ncrowson@sjmc.org

Insights

Pyoderma gangrenosum (PG) pathogenesis remains unclear, making diagnosis difficult. This review details PG

Area of Science:

  • Dermatology
  • Pathology

Background:

  • Pyoderma gangrenosum (PG) pathogenesis is poorly understood since its 1930 description.
  • Histopathologic differentiation of PG from other ulcerative conditions with dermal neutrophilia is challenging.
  • Accurate diagnosis requires integrating clinical history with biopsy findings.

Purpose of the Study:

  • To review the clinicopathologic features of pyoderma gangrenosum.
  • To summarize systemic diseases associated with PG.
  • To briefly discuss treatment options for PG.

Main Methods:

  • Literature review of pyoderma gangrenosum.
  • Analysis of clinical and pathological data.
  • Summary of associated systemic diseases and treatments.

Main Results:

  • Detailed description of various clinicopathologic forms of PG.
  • Compilation of systemic diseases associated with PG from literature and clinical experience.
  • Overview of current treatment strategies for PG.

Conclusions:

  • Diagnosis of PG necessitates a comprehensive approach beyond biopsy findings.
  • Understanding clinical features and associated diseases is crucial for accurate diagnosis and patient care.
  • This review provides a consolidated resource for pathologists and clinicians managing PG.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...